GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » ExamWorks Group Inc (NYSE:EXAM) » Definitions » EBITDA per Share

ExamWorks Group (ExamWorks Group) EBITDA per Share : $2.84 (TTM As of Mar. 2016)


View and export this data going back to 2010. Start your Free Trial

What is ExamWorks Group EBITDA per Share?

ExamWorks Group's EBITDA per Share for the three months ended in Mar. 2016 was $0.71. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2016 was $2.84.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for ExamWorks Group's EBITDA per Share or its related term are showing as below:

EXAM's 3-Year EBITDA Growth Rate is not ranked *
in the Insurance industry.
Industry Median: 14.6
* Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.

ExamWorks Group's EBITDA for the three months ended in Mar. 2016 was $30.0 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.


ExamWorks Group EBITDA per Share Historical Data

The historical data trend for ExamWorks Group's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExamWorks Group EBITDA per Share Chart

ExamWorks Group Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EBITDA per Share
Get a 7-Day Free Trial 1.52 1.86 2.18 2.60 2.71

ExamWorks Group Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.72 0.72 0.69 0.71

ExamWorks Group EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

ExamWorks Group's EBITDA per Share for the fiscal year that ended in Dec. 2015 is calculated as

EBITDA per Share(A: Dec. 2015 )
=EBITDA/Shares Outstanding (Diluted Average)
=116.423/43.044
=2.70

ExamWorks Group's EBITDA per Share for the quarter that ended in Mar. 2016 is calculated as

EBITDA per Share(Q: Mar. 2016 )
=EBITDA/Shares Outstanding (Diluted Average)
=30.038/42.362
=0.71

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ExamWorks Group  (NYSE:EXAM) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


ExamWorks Group EBITDA per Share Related Terms

Thank you for viewing the detailed overview of ExamWorks Group's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ExamWorks Group (ExamWorks Group) Business Description

Traded in Other Exchanges
N/A
Address
ExamWorks Group Inc was incorporated as a Delaware corporation on April 27, 2007. The Company is a provider of independent medical examinations, or 'IMEs', peer and bill reviews, and other related services, which include legal support services, administrative support services and medical record retrieval services. It provides these IME services through its medical panel of independently contracted, credentialed physicians and other medical providers. Its geographic segments include the United States, Canada, the United Kingdom and Australia. The Company's clients include property and casualty insurance carriers, law firms, third-party claim administrators, and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals for workers' compensation, automotive, personal injury liability and disability insurance coverage. It helps its clients manage costs and enhance their risk management processes by verifying the validity, nature, cause and extent of claims, identifying fraud and providing fast, efficient and quality IME services. It provides the clients with local presence, expertise and geographic coverage increasingly required. The Company's size and geographic reach give its clients access to its medical panel of physicians and other medical providers and proprietary information technology infrastructure that has been specifically designed to streamline the complex process of coordinating referrals, scheduling appointments, complying with regulations and client reporting. The Company's primary service is to provide IMEs that give its clients authoritative and accurate answers to questions regarding the nature and permanency of medical conditions or personal injury, their cause and appropriate treatment. Additionally, it provides peer and bill reviews, which consist of medical opinions by members of its medical panel without conducting physical exams, and the review of physician and hospital bills to examine medical care rendered and its conformity to accepted standards of care. Its primary competitors include companies and individual physicians in one or more services similar to those offered by the Company on a local or regional basis as well as insurance companies and other organizations which have established an in-house capability of performing such services. As a Company involved in the provision of IME services, it is subject to certain federal, state and local laws and regulations.
Executives
Fernandez De Castro Jose Miguel officer: CFO, Senior EVP and Treasurer TURBOCHEF TECHNOLOGIES, INC., SIX CONCOURSE PARKWAY, SUITE 1900, ATLANTA GA 30328
Richard E Perlman director, officer: Executive Chairman C/O TURBOCHEF TECHNOLOGIES, INC., SUITE 1900, SIX CONCOURSE PARKWAY, ATLANTA GA 30328
James K Price director, officer: Chief Executive Officer C/O TURBOCHEF TECHNOLOGIES, INC., SUITE 1900, SIX CONCOURSE PARKWAY, ATLANTA GA 30328
J Thomas Presby director 198 KEELER ROAD, BRIDGEWATER CT 06752
William A Shutzer director C/O TIFFANY & CO LEGAL DEPT, 727 FIFTH AVE, NEW YORK NY 10022
David B Zenoff director 3250 VAN NESS AVENUES, SAN FRANCISCO CA 94109
Peter Graham director C/O ONE BETTER VENTURES, 1122 OBERLIN ROAD, RALEIGH NC 27605
Joshua W. Lemaire officer: VP, Sales & Marketing 1 PARK PLAZA, SUITE 1000, IRVINE CA 92614

ExamWorks Group (ExamWorks Group) Headlines

From GuruFocus

ExamWorks Reports Insider Buys

By Monica Wolfe Monica Wolfe 03-05-2013

Baron Funds Comments on ExamWorks Group

By Holly LaFon Holly LaFon 08-10-2016

Baron Funds Comments on ExamWorks Group

By Holly LaFon Holly LaFon 02-25-2016

CEOs Reporting Insider Buys Costing Over $100,000

By Monica Wolfe Monica Wolfe 06-04-2013